Thembi Xulu has recently discovered that she can be a dealmaker. She’s leading the way for South Africa to make the anti-HIV jab, lenacapavir, on home soil.
To do this, the CEO of South Africa’s National Aids Council needs to get people and bodies with competing interests on one page — from profit-driven drug makers to the government to activists.
She’s on her way to the International Aids Conference kicking off in Rio de Janeiro on Sunday t…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.